99.1% PURITY
ERR AGONIST · ENDURANCE RESEARCH
SLU-PP-332
5 mg vial · lyophilized
A pan-ERR (estrogen-related receptor) agonist — a novel small molecule investigated as an 'exercise mimetic' for its ability to upregulate the same pathways activated by endurance training.
Half-Life
Under investigation (early-stage compound)
Storage
Lyophilized: 2–8 °C, protected from light. Reconstituted: 2–8 °C, use within 14 days.
A pan-ERR (estrogen-related receptor) agonist — a novel small molecule investigated as an 'exercise mimetic' for its ability to upregulate the same pathways activated by endurance training.
Who it's for
Endurance, mitochondrial, and 'exercise-mimetic' researchers.
Key things to know
- •Subcutaneous protocols are most common in published animal work.
- •Synergizes with actual training rather than replacing it.
- •Activates oxidative slow-twitch fiber programming over weeks.
- •Early-stage compound — long-term safety remains under investigation.
Research Highlights
- •Billon et al. (2024) — 'exercise in a pill' coverage; sustained running improvements in mice without training
